CompanyProfileSukuk

Actions

Middle East Healthcare Company (Saudi German Health) Sukuk

5019
Saudi German Health Sukuk
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Sukuk/Bonds Index
Historical

Stats Overview

  • Prev. Close 100.100
  • Open 100.100
  • High 100.100
  • Low 100.000
  • Nominal Value
    Traded (Sar)     1,204,000
  • Value Traded (Sar) 1,204,078.000
  • No. Of Trades 26
  • Avg. Trade Size 46,307.69

Last Trade

  • Date/Time 25-04-2024
    14:57:42
  • Yield -
  • Price 100.020
  • Nominal Value Traded (Sar) 27,000

Best Bid

  • Yield -
  • Price 100.000
  • Volume 44,000

Best Offer

  • Yield -
  • Price 100.020
  • Volume 8,000

Coupon Payments

Coupon Period

From To Number Of Days To Coupon Coupon Rate Payment Per Sukuk/Bond (SAR) Trading Suspension Period From Trading Suspension Period To
2024-03-06 2024-06-06 90 7.20000 18.0000 0000-00-00 0000-00-00
  • Average Trade Size = Cumulative / # Of Trades
  • Mo: Market Order

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

Apply Selected

CompanyProfileSukukv2Announcement

Actions
Jump To:
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Announcements

Announcements
  • A
    4009 SAUDI GERMAN HEALTH
     -2.04%

    Middle East Healthcare Co. (Saudi German Health) Announces Non-distribution of Cash Dividends to Shareholders for Financial Year of 2023

    1445/09/21     31/03/2024 08:35:27
  • A
    4009 SAUDI GERMAN HEALTH
     -2.04%

    Middle East Healthcare Co. announces its Annual Financial results for the period ending on 2023-12-31

    1445/09/21     31/03/2024 07:49:22
  • A
    4009 SAUDI GERMAN HEALTH
     -2.04%

    Middle East Healthcare Co. (Saudi German Health) Announces the Completion of Issuing Sukuk Denominated in SAR.

    1445/08/16     26/02/2024 09:22:02
  • A
    4009 SAUDI GERMAN HEALTH
     -2.04%

    Middle East Healthcare Company announces the commencement of the offer and subscription in its Sukuk denominated in SAR

    1445/08/02     12/02/2024 08:07:52
  • A
    4009 SAUDI GERMAN HEALTH
     -2.04%

    Middle East Healthcare Company (Saudi German Health) Announces the Opening of the Saudi German Hospital Project in Alexandria at Egypt (Related Party) Under the Administrative Supervision Agreement

    1445/07/27     08/02/2024 15:39:06
View All Announcements

CompanyProfileSukukv2Financials

Actions
Jump To:
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Financials

  • FINANCIAL INFORMATION
  • FINANCIAL STATEMENTS AND REPORTS
  • Annually
  • Quarterly
Balance Sheet 2023-12-31
Total Assets
5,173,150
 - - -
Total Liabilities
3,608,388
 - - -
Total Shareholders Equity (After Deducting the Minority Equity)
1,519,080
 - - -
Total Liabilities and Shareholders Equity
5,173,150
 - - -
Statement of Income 2023-12-31
Total Revenue (Sales/Operating)
2,653,170
 - - -
Net Profit (Loss) before Zakat and Tax
198,159
 - - -
Zakat and Income Tax
-17,983
 - - -
Net Profit (Loss) after Zakat and Tax
180,176
 - - -
Total Comprehensive Income
154,119
 - - -
Profit (Loss) per Share
1.96
 - - -
Cash Flows 2023-12-31
Net Cash From Operating Activities
191,083
 - - -
Net Cash From Investing Activities
-241,989
 - - -
Net Cash From Financing Activities
79,726
 - - -
Cash and Cash Equivalents, Beginning of the Period
15,602
 - - -
Cash and Cash Equivalents, End of the Period
44,423
 - - -
All Figures are in Thousands
All Currency In SAR
Last Update Date 2024-04-03
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Balance Sheet 2023-09-30
Total Assets
4,986,420
 - - -
Total Liabilities
3,428,705
 - - -
Total Shareholders Equity (After Deducting the Minority Equity)
1,510,009
 - - -
Total Liabilities and Shareholders Equity
4,986,420
 - - -
Statement of Income 2023-09-30
Total Revenue (Sales/Operating)
671,047
 - - -
Net Profit (Loss) before Zakat and Tax
58,028
 - - -
Zakat and Income Tax
-4,725
 - - -
Net Profit (Loss) after Zakat and Tax
53,303
 - - -
Total Comprehensive Income
54,125
 - - -
Profit (Loss) per Share
0.58
 - - -
Cash Flows 2023-09-30
Net Cash From Operating Activities
163,891
 - - -
Net Cash From Investing Activities
-185,141
 - - -
Net Cash From Financing Activities
70,862
 - - -
Cash and Cash Equivalents, Beginning of the Period
15,602
 - - -
Cash and Cash Equivalents, End of the Period
65,214
 - - -
All Figures are in Thousands
All Currency In SAR
Last Update Date 2023-11-05
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Display Previous Periods

CompanyProfileSukukv2Fund

Actions
Jump To :
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Issuance Profile


Issuance Information
Issuer Middle East Healthcare Co.
Listing Date 2024-03-13
Lead Manager Alrajhi Capital Company
Instrument Credit Rating Not rated
Debt Instrument Status Senior, Unsecured
Debt Instrument Type and Structure Mudaraba, Murabaha
Accumulative Issuance Amount (SAR) 1,000,000,000
Issue Date 2024-03-06
Maturity and Early Redemption Date 2029-03-06
Floating Interest Rate -
Coupon Rate % 7.2
Coupon Distribution Frequency Quarterly
Zakat treatment -
Trading Method Electronic
Collateral None
Minimum Subscription Amount Per Investor -
Par Value 1,000
Identification Code SA16100IEDJ2
Additional Information
Registrar Securities Depository Center Company (Edaa)
Payment Administrator Alrajhi Capital Company
Debt Instrument Agent Alrajhi Capital Company
Jump To :
  • Announcements
  • Financials
  • Issuance Profile
  • Issuer Profile

Issuer Overview

Construct, manage, operate and maintenance for hospitals, clinics, centers, institutes, rehabilitation centers, physiotherapy, laboratory, X-Ray, pharmacies, purchasing of lands to construct buildings and investment for the company in medical projects.

Issuer History

Middle East Healthcare Company (MEAHCO) is a closed joint stock company incorporated pursuant to the Ministerial Resolution number 2554 dated 16/03/1425H (corresponding to 05/05/2004G) and registered under commercial registration number 4030149460 dated 06/04/1425H (corresponding to 25/05/2004G) with a paid-up share capital of (SAR 590000000) five hundred and ninety million Saudi Riyals, of which (SAR 42040000) forty-two million and forty thousand Saudi Riyals were paid through cash contributions, while the remaining (SAR 547960000) five hundred and forty seven million and nine hundred and sixty thousand Saudi Riyals were paid through in kind contributions made by BAB consisting of SGH Madinah (including its land and buildings) SGH Aseer (including its land and buildings) and shares representing 80% of the share capital of BABAS (former owner and operator of SGH Riyadh) On 02/02/1435H (corresponding to 5/12/2013G) the EGA of the Company agreed to increase the Companies share capital from (SAR 590000000) five hundred ninety million Saudi Riyals to (SAR 767000000) seven hundred sixty seven million Saudi Riyals The increase of (SAR 177000000) one hundred and seventy seven million Saudi Riyals was covered through capitalization of the Shareholders account that resulted from their offering of additional in kind contributions to the Company which consisted of the following 1 SGH Jeddah 2 98% of the shares of AJ Sons 3 39.96% of NHCs share capital 4 Management Supervision Agreements for hospitals owned by third parties outside the Kingdom located in Dubai (UAE) Cairo (Egypt) and Sanaa (Yemen) 5 20% of BABAS which resulted in the Company fully owning BABAS and therefore fully owning SGH Riyadh which was later converted into a fully owned branch by the Company under commercial registration number 1010162269 dated 24/07/1421H (corresponding to 21/10/2000G) and a plot of land in the city of Dammam with a surface area of (30,000) thirty thousand m2 (Dammam Land) On 28/7/1436H (corresponding to 17/5/2015G) the EGA agreed to further increase the Companies share capital from (SAR 767000000) seven hundred and sixty-seven million Saudi Riyals to (SAR 920400000) nine hundred and twenty million four hundred thousand Saudi Riyals The increase of (SAR 153400000) one-hundred and fifty-three million four hundred thousand Saudi Riyals was covered through capitalization of the retained earnings account.

Equity Profile
Authorized Capital (SAR) 920,400,000 Issued Shares 92,040,000 Paid Capital (SAR) 920,400,000
Per Value/Share 10 Paid up Value/Share 10 Last Update
  • Basic Information
  • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION

  • Date Established

    2004/05/05

  • Financial Year End

    31//12

  • Listing Date

    2016-03-29

  • External Auditors

    Ernst & Young (EY)

  • Number Of Employees

    4322

  • Chairman

    • SOBHI ABDULJALEEL A. BATTRJEE
    Non - Executive

    SOBHI ABDULJALEEL A. BATTRJEE
    • BD Session Start
      2020-09-17
      Designation
      Chairman
    • BD Session End
      2023-09-16
      Classification
      Non - Executive
    Companies Membership
    • Membership Name
      NATIONAL HAIL CO. FOR HEALTHCARE
      Start Date
      2007-07-16
    • Membership Character
      Non executive
      End Date
      2018-11-06
    • Membership Name
      BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
      Start Date
      2015-08-11
    • Membership Character
      Non executive
      End Date
      2020-08-10

  • Board of Directors

    • Makarem Sobhi A. Batterjee
    Non - Executive

    Makarem Sobhi A. Batterjee
    • BD Session Start
      2020-09-17
      Designation
      Board of Directors
    • BD Session End
      2023-09-16
      Classification
      Non - Executive
    Companies Membership
    • Membership Name
      NATIONAL HAIL CO. FOR HEALTHCARE
      Start Date
      2007-07-16
    • Membership Character
      Non executive
      End Date
      2018-11-06
    • Membership Name
      BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
      Start Date
      2015-08-11
    • Membership Character
      Non executive
      End Date
      2020-08-10

    Khalid Abduljaleel Ibrahim Batterjee
    Non - Executive

    Khalid Abduljaleel Ibrahim Batterjee
    • BD Session Start
      2020-09-17
      Designation
      Board of Directors
    • BD Session End
      2023-09-16
      Classification
      Non - Executive
    Companies Membership
    • Membership Name
      NATIONAL HAIL CO. FOR HEALTHCARE
      Start Date
      2007-07-16
    • Membership Character
      Non executive
      End Date
      2018-11-06
    • Membership Name
      BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
      Start Date
      2015-08-11
    • Membership Character
      Non executive
      End Date
      2020-08-10

    Mohammed Abdulrahman Moumena
    Independent

    Mohammed Abdulrahman Moumena
    • BD Session Start
      2020-09-17
      Designation
      Board of Directors
    • BD Session End
      2023-09-16
      Classification
      Independent
    Companies Membership
    • Membership Name
      company of Alkhabeer Capital
      Start Date
      2012-01-01
    • Membership Character
      Non Executive
      End Date
      2018-01-01

    AMR MOHAMED KHALID KHASHOGGI
    Independent

    AMR MOHAMED KHALID KHASHOGGI
    • BD Session Start
      2020-09-17
      Designation
      Board of Directors
    • BD Session End
      2023-09-16
      Classification
      Independent
    Companies Membership
    • Membership Name
      Al Ahli Takaful Company
      Start Date
      2010-01-01
    • Membership Character
      Independent
      End Date
      2019-07-31

    Sultan Sobhi A. Batterjee
    Non - Executive

    Sultan Sobhi A. Batterjee
    • BD Session Start
      2020-09-17
      Designation
      Board of Directors
    • BD Session End
      2023-09-16
      Classification
      Non - Executive
    Companies Membership
    • Membership Name
      BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
      Start Date
      2015-08-11
    • Membership Character
      Non Executive
      End Date
      2020-08-10

    Mohammad Mustafa Bin Mohammad Omar Bin Siddiq
    Independent

    Mohammad Mustafa Bin Mohammad Omar Bin Siddiq
    • BD Session Start
      2020-09-17
      Designation
      Board of Directors
    • BD Session End
      2023-09-16
      Classification
      Independent
    Companies Membership
    • Membership Name
      Buruj Cooperative Insurance Company
      Start Date
      2013-01-07
    • Membership Character
      Out of the board
      End Date
      2022-03-08

  • Senior Executives

    • AHMED MOHAMED SHEBL AHMED ELATREES
    CEO

    AHMED MOHAMED SHEBL AHMED ELATREES
    • BD Session Start
      2018-12-01
      Designation
      Senior Executives
    • BD Session End
      -
      Classification
      CEO

    MADANI BAHYELDIN ABBAS HOZAIEN
    CFO

MADANI BAHYELDIN ABBAS HOZAIEN
  • BD Session Start
    2019-06-30
    Designation
    Senior Executives
  • BD Session End
    -
    Classification
    CFO

Investor Relations

Contact Name

MUATH MOHAMMED ALZARKAN

Address :

Jeddah, Batterjee Street, Al Zahra District P.O.BOX2550 Jeddah 21461

Contact Details :

Telephone : 0966-12-2606000
FAX : 00966-12-6835874
Email : president4@sghgroup.net

Website :

www.meahco.sa

Add To Watchlist
In your Watchlist
Add To Watchlist

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.